Abstract

Transient leukaemia--a benign form of leukaemia in newborn infants with trisomy 21.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Chromosome copy number and leukemia–Lessons from Down's syndrome
Shai Izraeli
Hematology | VOL. 10
Shai IzraeliShai Izraeli
01 Sep 2005
Distinct gene signatures of transient and acute megakaryoblastic leukemia in Down syndrome.
M Albert ... J Lightfoot
Leukemia | VOL. 18
M Albert, et. al.M Albert ... J Lightfoot
02 Sep 2004
Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Shawn E Holt ... Alvin Zipursky
Journal of pediatric hematology/oncology | VOL. 24
Shawn E Holt, et. al.Shawn E Holt ... Alvin Zipursky
01 Jan 2002
GATA1 Mutations in Transient Leukemia and Myeloid Leukemia in “Down” Syndrome.
Christine Von Neuhoff ... Arnulf Pekrun
Blood | VOL. 112
Christine Von Neuhoff, et. al.Christine Von Neuhoff ... Arnulf Pekrun
16 Nov 2008
View more papers

More From: British journal of haematology

Paper Title
Journal
Date
Author
Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T-cell therapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Tamer Othman ... Ibrahim Aldoss
British journal of haematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Ibrahim Aldoss
29 May 2024
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the I-BFM Study Group.
Herbert Pichler ... Adriana Balduzzi
British journal of haematology | VOL. -
Herbert Pichler, et. al.Herbert Pichler ... Adriana Balduzzi
27 May 2024
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart ... Michael Crump
British journal of haematology | VOL. -
Douglas A Stewart, et. al.Douglas A Stewart ... Michael Crump
27 May 2024
RUNX1::ETO and CBFβ::MYH11 converge on aberrant activation of BCAT1 to confer a therapeutic vulnerability in core-binding factor-acute myeloid leukaemia.
Siyang Wang ... Kankan Wang
British journal of haematology | VOL. -
Siyang Wang, et. al.Siyang Wang ... Kankan Wang
27 May 2024
View more papers